Failing to cover Alzheimer’s therapies a costly proposition: researchers
By
Kimberly Bonvissuto
Jun 16, 2023
Not managing Alzheimer’s disease and related dementias is a costly proposition not just to families, but also to society, according to two recent studies.
Telemedicine increases access to care for assisted living residents with dementia: study
By
Kimberly Bonvissuto
May 30, 2023
Although racial/ethnic and socioeconomically disadvantaged populations were less likely to use telemedicine early in the COVID-19 pandemic, a new study finds that telemedicine offered a way for members...
Lawmakers turn up heat on CMS to expand access to Alzheimer’s treatments
By
Kimberly Bonvissuto
Apr 28, 2023
Medicare needs to reconsider its national coverage decision on FDA-approved Alzheimer’s drug treatments, bipartisan members of the House told Centers for Medicare & Medicaid Services Administrator Chiquita...
Religious needs during pandemic more likely to be unmet among people living with dementia
By
Kimberly Bonvissuto
Mar 29, 2023
Although quality end-of-life care generally was preserved during the COVID-19 pandemic, people living with dementia in the United States were more likely to have unmet religious needs than those without...
Intrinsic capacity assessments more effective than disease management in promoting healthy aging: study
By
Kimberly Bonvissuto
Mar 28, 2023
Focusing on older adults’ mental and physical capacities could be more effective than disease management in promoting healthy aging in older adults, according to the results of a new study.
Care navigation can supplement dementia care workforce, fill in care gaps: report
By
Kimberly Bonvissuto
Mar 23, 2023
Investing in care navigation — and care navigators — will help individuals living with Alzheimer’s disease and related dementias and their caregivers overcome barriers, according to a new report...
‘Alzheimer’s crisis’ intersecting with direct care workforce challenges, association says
By
Kimberly Bonvissuto
Mar 16, 2023
The nation is facing an “Alzheimer’s crisis” as the number of older adults in whom the disease is diagnosed continues to increase amid a shortage of direct care workers, according to the Alzheimer’s...
Inconsistent state regulations, staff training produce wide variations among states’ antipsychotic...
By
Kimberly Bonvissuto
Feb 28, 2023
Researchers are calling for a closer look at the use of antipsychotics among assisted living residents with dementia after a study found wide variations in prescribing patterns.
Advocates ‘appalled’ as CMS again says it will not cover monoclonal antibody treatments for Alzheimer’s
By
Kimberly Bonvissuto
Feb 24, 2023
Advocates of those living with Alzheimer’s disease are expressing disappointment that the Centers for Medicare & Medicaid Services on Wednesday rejected a request to expand its coverage of monoclonal...
Bipartisan group pushes CMS to expand coverage for Alzheimer’s treatments
By
Kimberly Bonvissuto
Feb 21, 2023
Access to federally approved monoclonal antibody and other disease-modifying therapies for Alzheimer’s disease will be “extremely limited” unless the Centers for Medicare & Medicaid Services reconsiders...